| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
37,750,000 |
| Market
Cap: |
473.01(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$5.77 - $16.73 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Liquidia is a biopharmaceutical company focused on the development, manufacturing and commercialization of products with focus directed towards the treatment of pulmonary hypertension (PH). Co. conducts research and manufacturing of products by applying its proprietary PRINT® technology, a particle engineering platform. Co.'s products and candidates for PH include: YUTREPIATM (treprostinil) Inhalation Powder to Treat PAH, which is an inhaled dry powder formulation of treprostinil; and Treprostinil Injection, a Generic Version of Remodulin®, which contains the same active ingredient, same strength, same dosage forms and same inactive ingredient amounts as Remodulin®.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Eshelman Fredric N |
10% Owner |
– – • |
2020-11-25 |
4 |
S |
$3.13 |
$54,349 |
D/D |
(17,364) |
6,570,569 |
|
14% |
|
| Eshelman Fredric N |
10% Owner |
– – • |
2020-11-24 |
4 |
S |
$3.15 |
$894,247 |
D/D |
(283,465) |
6,587,933 |
|
19% |
|
| Eshelman Fredric N |
10% Owner |
– – • |
2020-11-23 |
4 |
S |
$3.16 |
$421,347 |
D/D |
(133,346) |
6,871,398 |
|
12% |
|
| Eshelman Fredric N |
10% Owner |
– – • |
2020-11-19 |
4 |
D |
$3.35 |
$100,500 |
D/D |
(30,000) |
7,004,744 |
|
- |
|
| Eshelman Fredric N |
10% Owner |
– – • |
2020-07-02 |
4 |
B |
$8.00 |
$15,000,000 |
D/D |
1,875,000 |
7,034,744 |
2.45 |
-46% |
|
| Maynor Benjamin |
SVP, Research and Development |
• – – |
2020-05-27 |
4 |
D |
$9.06 |
$23,348 |
D/D |
(2,577) |
9,158 |
|
- |
|
| Maynor Benjamin |
SVP, Research and Development |
• – – |
2020-05-27 |
4 |
OE |
$2.69 |
$12,788 |
D/D |
4,754 |
11,735 |
|
- |
|
| Maynor Benjamin |
SVP, Research and Development |
• – – |
2020-04-14 |
4 |
D |
$6.23 |
$20,677 |
D/D |
(3,319) |
6,981 |
|
- |
|
| Maynor Benjamin |
SVP, Research and Development |
• – – |
2020-04-14 |
4 |
OE |
$1.85 |
$11,344 |
D/D |
6,132 |
10,300 |
|
- |
|
| Eshelman Fredric N |
10% Owner |
– – • |
2020-04-06 |
4 |
B |
$5.28 |
$233,715 |
I/I |
44,250 |
175,573 |
1.5 |
2% |
|
| Eshelman Fredric N |
10% Owner |
– – • |
2020-04-03 |
4 |
B |
$4.85 |
$169,740 |
I/I |
35,000 |
131,323 |
1.5 |
12% |
|
| Eshelman Fredric N |
10% Owner |
– – • |
2020-04-02 |
4 |
B |
$4.96 |
$35,792 |
I/I |
7,223 |
96,323 |
1.5 |
8% |
|
| Eshelman Fredric N |
10% Owner |
– – • |
2020-04-01 |
4 |
B |
$4.89 |
$220,122 |
I/I |
45,000 |
89,100 |
1.5 |
11% |
|
| Eshelman Fredric N |
10% Owner |
– – • |
2020-03-31 |
4 |
B |
$4.87 |
$146,112 |
I/I |
30,000 |
44,100 |
1.5 |
21% |
|
| Eshelman Fredric N |
10% Owner |
– – • |
2020-03-30 |
4 |
B |
$4.76 |
$67,106 |
I/I |
14,100 |
14,100 |
1.5 |
28% |
|
| Katz Richard D |
Chief Financial Officer |
• – – |
2020-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,833 |
10,833 |
|
- |
|
| Lippe Robert A |
Chief Operations Officer |
• – – |
2020-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,833 |
28,360 |
|
- |
|
| Thomas Jeri |
SVP, Commercial |
• – – |
2020-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
8,333 |
8,333 |
|
- |
|
| Maynor Benjamin |
SVP, Research and Development |
• – – |
2020-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
8,333 |
12,501 |
|
- |
|
| Roscigno Robert F |
SVP, Product Development |
• – – |
2020-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
8,333 |
8,333 |
|
- |
|
| Krawchick Florina |
SVP, Human Resources |
• – – |
2020-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
16,991 |
|
- |
|
| Fowler Neal Franklin |
Chief Executive Officer |
• • – |
2020-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
30,400 |
86,627 |
|
- |
|
| Bloch Stephen M |
Director |
– • – |
2019-12-27 |
4 |
A |
$3.13 |
$999,997 |
I/I |
319,488 |
2,917,169 |
|
- |
|
| Canaan Partners Viii Llc |
10% Owner |
– – • |
2019-12-27 |
4 |
B |
$3.13 |
$999,997 |
D/D |
319,488 |
2,917,169 |
2.45 |
- |
|
| Eshelman Fredric N |
10% Owner |
– – • |
2019-12-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,159,744 |
|
- |
|
78 Records found
|
|
Page 1 of 4 |
|
|
0.16 (1.29%) 
